| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| exploratory endpoints in clinical trials | 0.2 | 0.6 | 7938 | 28 | 40 |
| exploratory | 0.64 | 0.4 | 9453 | 71 | 11 |
| endpoints | 1.53 | 0.7 | 5790 | 88 | 9 |
| in | 1.34 | 0.3 | 1365 | 73 | 2 |
| clinical | 1.49 | 0.8 | 7285 | 99 | 8 |
| trials | 1.99 | 0.1 | 2734 | 59 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| exploratory endpoints in clinical trials | 1.93 | 0.7 | 1166 | 34 |
| endpoints in clinical trials | 0.78 | 0.3 | 1911 | 8 |
| endpoints in oncology clinical trials | 0.16 | 0.7 | 2841 | 91 |
| examples of endpoints in clinical trials | 1.38 | 0.6 | 4305 | 88 |
| multiple endpoints in clinical trials | 1.54 | 0.5 | 4153 | 15 |
| primary endpoints in clinical trials | 1.28 | 0.8 | 410 | 12 |
| types of endpoints in clinical trials | 1.44 | 1 | 9121 | 79 |
| secondary endpoints in clinical trials | 1.82 | 0.2 | 2768 | 27 |
| endpoints in oncology clinical trials ppt | 0.15 | 0.2 | 1677 | 77 |
| safety endpoints in clinical trials | 1.79 | 0.7 | 8725 | 81 |
| exploratory analysis clinical trial | 1.16 | 0.5 | 9298 | 21 |
| multiple endpoints in clinical trials fda | 0.44 | 0.9 | 7402 | 49 |
| objectives and endpoints in clinical trials | 1.59 | 0.1 | 8419 | 18 |
| oncology clinical trial endpoints | 1.92 | 0.1 | 3630 | 97 |
| what are clinical trial endpoints | 1.03 | 0.5 | 731 | 40 |
| what is an exploratory endpoint | 1.88 | 0.7 | 4069 | 77 |
| clinical trial endpoints fda | 1.12 | 1 | 1397 | 58 |
| clinical trial primary endpoint | 0.86 | 0.4 | 1820 | 33 |
| clinical trial secondary endpoint | 1.18 | 0.3 | 4116 | 25 |
